AI framework helps identify new targets for CAR T cell therapy

Researchers at the University of Pennsylvania have developed a computational framework designed to identify new protein targets for CAR T cell therapy. By analyzing genomic data, the tool helps scientists pinpoint markers on cancer cells that are less likely to cause unintended damage to healthy tissue. This approach aims to streamline the development of more precise immunotherapies and reduce potential side effects for patients.